The International Patient Services at the Hong Kong Sanatorium & Hospital (HKSH) takes a personalised approach to providing our guests with the most effective and efficient care possible. With a strong tradition of excellence in successful treatment and state-of-art facilities, the HKSH provides services for overseas patients who seek physician consultations, second medical opinions, specialised surgical procedures, and full range of comprehensive oncology treatments.

Our team is here to ensure personalized, seamless and streamlined services for patients seeking treatment in HKSH. Each visiting patient is assigned with a dedicated member of our medical concierge team, who offers personal assistance from the initial phone call to the post treatment records delivery. We hope, by supporting every aspects of the patient journey, to enable our patients to focus on treatment and recovery.


The Comprehensive Oncology Centre offers comprehensive and multidisciplinary cancer management to patients. The Centre comprises a team of medical specialists and professional nurses, is equipped with high-end medical technologies and endeavors to provide quality clinical diagnosis and the most suitable treatment in various modalities, including surgery, radiotherapy, chemotherapy, targeted therapy, immunotherapy, radionuclide therapy and autologous peripheral blood stem cell transplantation.

Supporting services of professional patient counselling, psychological support, pain management, physical fitness and dietary advices are also available.

Radiotherapy

Unity MR Linac integrates linear accelerator technology with real-time 1.5 Tesla (T) Magnetic Resonance Imaging (MRI) and advanced treatment planning into a single platform, allowing for unprecedented accuracy in image-guided daily adaptive radiotherapy.

Key features:
  • To see and track difficult-to-visualise soft-tissue anatomies with MR Imaging;
  • To provides insights to any changes in tumour size and position;
  • Adaptive radiation doses at the time of treatment;
  • To increase the precision in localising tumour; and
  • To reduce treatment margins and fraction regimens

As the next generation of helical radiation therapy technology, Radixact X9 supports effective and efficient delivery of precise radiation treatments for a full spectrum of cancer patients.

Key features:
  • Shortened scan time and treatment delivery time;
  • Delivery of individualised treatments for both routine and complex indications;
  • Megavoltage Computed Tomography imaging system for daily volumetric verification;
  • Delivery of image-guided, intensity-modulated radiation therapy to most parts of the body; and
  • Adaptive radiation therapy to keep track of anatomic and dose changes, initiate re-plan that ensures treatment outcome

Versa HD employs sophisticated conformal beam-shaping technology and high dose rates to achieve precision and speed for delivery of advanced stereotactic body radiotherapy (SBRT). It also offers the flexibility of conventional techniques and the newest imaging technology to aid in the visualisation and treatment of a broad range of tumours throughout the body.

Key features:
  • Shortened treatment time with market-leading multi-leaf collimator leaf travel speeds, ultra-low leaf transmission, and high dose rate delivery;
  • SBRT delivery within a reasonable time;
  • Reduced non-therapeutic doses to spare organs-at-risk for potentially decreased side effects and a lower risk of secondary cancer;
  • Custom configurations for specific clinical requirements; and
  • Soft tissue visualisation during treatment using the latest imaging technology



Radionuclide Therapy

Theranostics
Theranostics is a new concept in strategic treatment of cancer based on quantitative and longitudinal targeted molecular imaging, using the same biochemical molecules as imaging and therapeutic agents. Firstly, tracers with diagnostic radioisotopes (F-18, C-11, Ga-68, Tc-99m, I-123, etc.) are used for tomographic imaging with PET/CT and NM SPECT/CT to perform cancer staging, trace metastases, simulate treatment and predict effectiveness. Subsequently, tracers with therapeutic radioisotopes (I-131, Lu-177, Y-90, Ra-223 and Sr-89, etc.) emitting high energy radiation are applied to deliver highly specific treatment and their biodistribution inside body during therapy are captured for evaluation. Cancer therapy can thus be personalized and effectively monitored to improve survival and quality of life.

Private Radiation Isolation Rooms
To ensure radiopharmaceutical quality and safety, a series of stringent tests are performed in our Quality Control Laboratory before patient use. Under the care by nuclear medicine specialists, radiographers and nurses in our private radiation isolation rooms, the safety and well-being of patients during treatment can be maximized.

One-stop Full Spectrum Service
With a comprehensive clinical setting, we are the only NMPET centre in Hong Kong capable of providing a one-stop full spectrum service of radionuclide therapy for different cancers and other metabolic diseases.
Current scope of treatment services:
  • Lutetium-177 DOTATATE
  • Iodine-131 MIBG
  • Lutetium-177 PSMA
  • Iodine-131
  • Yttrium-90 Microspheres
  • Ytrrium-90 Zevalin radioimmunotherapy
  • Radium-223 Dichloride
  • Strontium-89 Chloride


Diagnostic Imaging

Hong Kong’s first PET/CT using SiPM technology was installed at our hospital in 2019, and we are the only local PET centre operating 3 units of this latest model to provide revolutionary services in cancer imaging.

With the finest detector element and the highest signal sensitivity providing the best image quality outperforming the industry, the scanners excel in detection of early tumour, enable precise quantification of tissue metabolism according to physiologic characteristics and molecular biochemical properties, evaluate treatment effectiveness and contribute to new applications in theranostics and parametric PET imaging.

Onsite radiopharmaceutical production is carried out in accordance with international guidelines including "Current Good Radio-Pharmacy Practice" (cGRPP) and "Current Good Manufacturing Practices" (cGMP). Our production suite, equipped with 4 Medical Cyclotrons, 2 Radiopharmacy Laboratories and a Quality Control Laboratory, specialises in synthesising close to 20 radiopharmaceuticals tagged with F-18, C-11 or Ga-68 for clinical use. Oncologists can obtain critical and valuable information to prescribe the most suitable treatment regime for patients.

PET/CT Simulation is a one-stop imaging facility for both metabolic evaluation and CT simulation in radiotherapy treatment planning. The efficacy of radiotherapy relies on maximizing radiation dose to tumour and preserving normal tissues. With the variety of PET tracers available, PET/CT can delineate the metabolic boundary, quantify aggressiveness and characterize tissue functional status (e.g. cellular differentiation and hypoxia) of targeted tumour.

Our PET/CT scanner with SiPM technology, equipped with an external laser positioning system and a flat indexing pallet, has a precise spatial co-registration and an outstanding image quality. Image data in a single PET/CT scan can streamline the workflow and personalize treatment plan. Biological tumor contours and functional data on PET images can be transferred directly to CT images for dosimetric calculation and dose boosting. Not only can it be used at pre-treatment stage but also within treatment course for interim assessment and adaptive planning.

Magnetic resonance imaging (MRI) is well known for providing superb soft tissue details for better tumour visualisation in cancer cases. Dedicated MR simulator allows patients being scanned under treatment position. This additionally offers excellent image matching to the planning CT, thus providing highly accurate target and organs at risk contours for treatment planning. It also ensures treatment dose being prescribed to the target volume precisely.

Now available in HKSH Eastern Medical Centre, Hong Kong’s first MAGNETOM Sola is the latest model of 1.5 Tesla MRI. Equipped with BioMatrix Technology, MAGNETOM Sola can automatically adjust to patient biovariability and overcome variations in MRI examinations. It can achieve fast and reliable results with higher diagnostic confidence and consistent, high-quality personalised examinations.

With Simultaneous Multi-Slice turbo spin echo (TSE), the system supports musculoskeletal (MSK) imaging with up to 46% reduction in scan time for an entire MSK examination.

MEGNETOM sola is also specially designed for, among others, imaging and biopsy with high SNR in both diagnostic and interventional setups, making it an ideal imaging equipment for cancers.

Unlike conventional CT scanners, SOMATOM Force can scan patients at a speed of up to 737 millimeters per second, at 0.24mm spatial resolution and at routinely low radiation dose and contrast media dose. The ultra-fast scan speed allows whole abdomen scanning in a fraction of 1 second without requiring the patients to hold breath frequently. The low-noise images with best-in-class spatial resolution enables delineation of fine details, giving doctors precise information for making accurate diagnoses.

Hologic 3 Dimensions system provides 3D mammographic images of higher quality and greater patient comfort during examination. This is clinically proven to have the ability to detect up to 65% more invasive breast cancers than the conventional 2D models, regardless of age or breast density. Curved compression surface mirrors the breast shape. It improves comfort without degrading image quality and increasing the time and radiation dose to patients.

Philips EPIQ 7 Premium ultrasound system has the superb capability of creating images of optimal resolution. Its PureWave transducer technology improves penetration and provides excellent detailed resolution.



The IVF Centre is a pioneer in using Next Generation / High Throughput Sequencing techniques in assisted reproductive technologies, as Pre-implantation Genetic Testing for Aneuploidies – Abnormal Number of Chromosomes (PGT-A) and Pre-implantation Genetic Testing for Monogenic Diseases /Chromosomal Structural Rearrangements (PGT-M/SR) (previously known as Pre-implantation Genetic Screening (PGS) and Pre-implantation Genetic Diagnosis (PGD)) are brought in for achieving higher pregnancy rate and a reduced risk of genetic abnormalities in the offspring.

The latest technology of intracytoplasmic sperm injection (ICSI) and the EmbryoScope time-lapse system provide an optimal environment for the embryo culture at the Centre. Gamete storage service is also provided to preserve one’s fertility for future use.

The Obstetrics & Gynaecology Centre is helmed by a team of top-notch specialists and clinical personnel. It offers a wide spectrum of gynaecological services, such as:
1. Minimally invasive gynaecology surgery
2. Gynaecological cancer surgery.
3. Female incontinence problem

The Centre also provides general obstetric services, e.g. pre-pregnancy and antenatal checkup. During pregnancy, women might face different unexpected problems, such as IUGR, pre-eclampsia. Our team of Maternal Fetal Medicine provides assessment, diagnosis and counselling services to women facing these problems during pregnancy.

Given the possible harm posed by reproductive health problems, our Reproductive Medicine team supports investigation and management of different menstrual problems, infertility, etc.

For over a decade, the HKSH Guy Hugh Chan Refractive Surgery Centre (Admiralty) and HKSH Eye Surgery Centre have been awarded the Reader Digest’s Trusted Brand Award (Eye Surgery Centre Category), where the former is Hong Kong’s first centre to perform LASIK and has performed the largest number of LASIK surgeries in Hong Kong.

Our specialists in Ophthalmology and professional personnel provide a comprehensive range of services ranging from LASIK, cataract, glaucoma, cornea and refractive surgery to other uncommon conditions. Ambulatory day surgeries and inpatient services for major eye surgeries are also available if necessary. Emergency consultations are conducted by on-duty Ophthalmologists throughout the year.

Being the first private hospital in Hong Kong to deliver living donor liver transplant services, we are led by internationally renowned liver surgeons with the most experienced medical experts and supported by cutting-edge medical technologies, the Liver Surgery and Transplant Centre provides holistic treatment for patients with liver cancer and other liver diseases.

Led by experienced otolaryngologists with advanced facilities, Li Shu Pui ENT Head & Neck Surgery Centre provides a wide spectrum of examinations, one-stop diagnosis and treatments with a specialized focus for head and neck cancer patients. Being the pioneer in the maxillary swing approach to the central skull base, recurrent nasopharyngeal carcinoma and other types of tumour in the vicinity can be removed adequately with minimal morbidity.

Depending on the extent of joint damage, either partial or total knee replacement is performed using robotic arm technology (Makoplasty) or computer-assisted navigation system respectively. Both technology can achieve high precision in implant positioning, minimise surgical trauma and attain excellent clinical outcome.

Robot-assisted partial knee replacement is a state-of-the-art treatment for patients with a partially damaged knee joint due to primary osteoarthritis, post-traumatic knee arthritis, osteonecrosis, etc. Computer-assisted total knee replacement surgery is a mature and reliable operation that promises great results.

Backed by highly experienced plastic surgeons with keen eyes for natural-looking outcomes, the Centre provides a wide array of aesthetic and reconstructive procedures, cosmetic surgery of eyelids, nose and breast, skin treatment procedures as well as non-invasive, minimally invasive and surgical means for enhancement of facial features and body contouring. The team also manages skin cancers, congenital skin lesions, head and neck cancers, and performs reconstructive surgeries for cancer and burn patients.


For Healthcare Professionals

Our team seeks to best prepare all potential patients to ensure any transfer of care back and forth will be as seamless as possible. If you see a need to approach us, please complete the Referral Form or contact us via the information below and one of our care manager will be able to initiate the process:

Tel.: +852 2835 3788
Email: IPS@hksh-hospital.com
Whatsapp:   +852 9183 3867, +852 5790 6058, +852 5790 6059, +852 9183 0177 (For non-emergency cases)
Please provide name and contact number in text message.
Our Centre will contact you by phone to confirm.
Do not send voice messages or graphics.


For Patient

Our team welcomes guests seeking medical treatment abroad by making access to HKSH’s high-quality care as convenient as possible. In order to begin the process, we ask patients to complete the Online Registration Form so that our team can refer you to the most appropriate doctor to meet your medical needs.


In view of the Emergency Response Level activated by the Hong Kong Government and the corresponding notification requirements, HKSH Medical Group has implemented a number of precautionary measures in order to safeguard against the outbreak of Coronavirus Disease 2019 (COVID-19). Guidelines are subject to change to reflect the latest COVID-19 situation in Hong Kong.

Patients who fulfill all entry criteria and compulsory quarantine requirements may be subjected to approval for undergoing quarantine at a medical facility if deemed to be necessary. Please refer to the Hong Kong government informative page for pre-boarding and arrival procedures at https://www.coronavirus.gov.hk/eng/index.html or contact the International Patient Services of HKSH for queries.

A family member with the next-of-kin relationship can accompany the patient to travel overseas. Both the patient and his/her accompanying caregiver must comply with the following criteria:

Pre-departure testing
  • Patient (and accompanying caregiver, if any) must test negative for COVID-19 by Polymerase Chain Reaction (PCR) test once, within 72 hours prior to departure
  • Patient must not have another of the following symptoms: fever, cough, runny nose, sore throat or fever within 72 hours prior to departure

On-arrival procedures
Foreign patients and their accompanying caregivers will be subjected to mandatory on-arrival procedures related to admission, quarantine and testing at our hospital. Details are listed as follow:
  • Patient and accompanying caregiver must be admitted to a private room at our hospital and received COVID-19 by PCR on day 1, 4 and 8 during the admission.
  • If arrival PCR test is negative, the patient can begin to receive the required specialist medical care that the patient had come for, if assessed o be appropriate by the attending specialist.

Please contact the IPS team of HKSH for more information and assistance.

A person issued with a compulsory quarantine order to stay at our hospital. The Officers of the Department of Health will monitor your movement and may contact you through multiple platforms. You will be escorted to any medical service outside of your room and no visitor will be allowed for the whole period of the quarantine.

The quarantine period will commence from the day of your arrival to Hong Kong and will cease at 11:59pm of the 14th or 21st day upon your arrival.


Go Top registration

CONTACT

E-MAIL

ADDRESS

REGISTRATION